Enteral Enhancement of Glucose Disposition by Both Insulin-Dependent and Insulin-Independent Processes: A Physiological Role of Glucagon-Like Peptide I
The DOI matches its Crossref record.
Abstract
Glucagon-like peptide I (GLP-I)(7–36) amide is secreted by intestinal L-cells in response to food ingestion. GLP-I is a potent insulin secretagogue and also inhibits glucagon release. Inaddition, when given to humans in pharmacological amounts, GLP-I increases glucose disposal independent of its effects on islet hormone secretion. To test the hypothesis that this extrapancreatic effect of GLP-I on glucose disposition is present at physiological levels of GLP-I, we performed intravenous glucose tolerance tests (IVGTTs) 1 h after the following interventions: 1) the ingestion of 50 g fat to stimulate GLP-I secretion or the ingestion of water as a control and 2) infusion of GLP-I to attain physiological levels or a control infusion of saline. The results of the IVGTTs were analyzed using the minimal model technique to determine the insulin sensitivity index (SI) and indexes of insulin-independent glucose disposition, glucose effectiveness at basal insulin (SG), and glucose effectiveness at zero insulin (GEZI), as wellas the glucose disappearance constant (kg) and the acute insulin response to glucose (AIRg). These parameters were compared between conditions of elevated circulating GLP-I and control conditions. After ingestion of fat and infusion of synthetic hormone, plasma GLP-I increased to similar levels; GLP-I did not change with water ingestion or saline infusion. Elevated levels of GLP-I, whether from fat ingestion or exogenous infusion, caused increased glucose disappearance (kg: fat versus water 2.67 ± 0.2 vs. 1.72 ± 0.2, P < 0.001; GLP-I versus saline 2.42 ± 0.2 vs. 1.96 ± 0.2 %/min, P = 0.045), insulin secretion (AIRg: fat versus water 427 ± 50 vs. 284 ± 41, P = 0.001; GLP-I versus saline 376 ± 65 vs. 258 ± 16 pmol/1, P = 0.03), and glucose effectiveness (SG: fat versus water 2.5 ± 0.1 vs. 1.8 ± 0.2, P = 0.001; GLP-I versus saline 2.5 ± 0.2 vs. 1.8 ± 0.2%/min, P = 0.014; GEZI: fat versus water 1.9 ± 0.2 vs. 1.3 ± 0.2%/min, P = 0.003; GLP-I versus saline 1.9 ± 0.2 vs. 1.3 ± 0.2,P = 0.006) but no difference in insulin sensitivity. These results suggestthat GLP-I, released after meals, promotes glucose assimilation both by augmenting insulin secretion and through a separate effect to increase glucose uptake and/or inhibit hepatic glucose output.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cited by
Kieffer, T. J., & Francis Habener, J. (1999) · Endocrine Reviews · doi:10.1210/edrv.20.6.0385 · Cited by 1,062
Scrocchi, L. A., Brown, T. J., Maclusky, N., Brubaker, P. L., Auerbach, A. B., Joyner, A. L., & Drucker, D. J. (1996) · Nature Medicine · doi:10.1038/nm1196-1254 · Cited by 793
The Brain, Appetite, and Obesity
Berthoud, H.-R., & Morrison, C. (2008) · Annual Review of Psychology · doi:10.1146/annurev.psych.59.103006.093551 · Cited by 641
Enhancing Incretin Action for the Treatment of Type 2 Diabetes
Drucker, D. J. (2003) · Diabetes Care · doi:10.2337/diacare.26.10.2929 · Cited by 579
Role of the Vagus Nerve in Mediating Proximal Nutrient-Induced Glucagon-Like Peptide-1 Secretion
Rocca, A. S., & Brubaker, P. L. (1999) · Endocrinology · doi:10.1210/en.140.4.1687 · Cited by 464
Metadata
- Authors
- D'Alessio, D. A., Prigeon, R. L., & Ensinck, J. W.
- Venue
- Diabetes
- Publisher
- American Diabetes Association
- Published
- 1995-12-01
- Volume
- 44
- Issue
- 12
- Pages
- 1433-1437
- ISSN
- 0012-1797 (ISSN-L)
- 1939-327X
- OpenAlex
- W2164609252
- Cited by
- 122
- References
- 0
- FWCI
- 4.60
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Enteral Enhancement of Glucose Disposition by Both Insulin-Dependent and Insulin-Independent Processes: A Physiological Role of Glucagon-Like Peptide I. https://app.cochat.ai/papers/10.2337/diab.44.12.1433
- The paper
- D'Alessio, D. A., Prigeon, R. L., & Ensinck, J. W. (1995). Enteral Enhancement of Glucose Disposition by Both Insulin-Dependent and Insulin-Independent Processes: A Physiological Role of Glucagon-Like Peptide I. Diabetes. https://doi.org/10.2337/diab.44.12.1433
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.